2018-2023 Global Nucleic Acid-based Therapeutics Market Report (Status and Outlook)

payment-methods.png
Secure Payment Methods

Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.

Over the next five years, LPI(LP Information) projects that Nucleic Acid-based Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

Global Nucleic Acid-based Therapeutics market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by ResearchVector Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Nucleic Acid-based Therapeutics to 2023 offers detailed coverage of guanidine Nucleic Acid-based Therapeutics industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Nucleic Acid-based Therapeutics producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Nucleic Acid-based Therapeutics Product details, including pictures and technical specifications
  • Nucleic Acid-based Therapeutics manufacturers, distributors and channels
  • Major players present in the Nucleic Acid-based Therapeutics
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Wave Life Sciences
  • Imugene
  • Caperna
  • Phylogica
  • Protagonist Therapeutics
  • Benitec Biopharma
  • EGEN
  • BioMedica
  • Transgene
  • Copernicus Therapeutics

Key regions:

United States, Canada, Mexico, Brazil, China, Japan, Korea, Southeast Asia, India, Australia, Germany, France, UK, Italy, Russia, Spain, Egypt, South Africa, Israel, Turkey, GCC Countries

Additionally, the market is segmented by the following sectors

  • Anti-Sense And Anti-Gene
  • Short Inhibitory Sequences
  • Nucleoside Analogs
  • Ribozymes
  • Aptamers
  • Segmentation by application:
  • Monogenetic Disorders
  • Multi-Genetic Disorders

Not only this, figures covering the end user applications are also provided according to the following classification

  • Monogenetic Disorders
  • Multi-Genetic Disorders

In summary, the report serves to study and analyse the Nucleic Acid-based Therapeutics size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nucleic Acid-based Therapeutics, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 2018-2023 Global Nucleic Acid-based Therapeutics Market Report (Status and Outlook)
  • 1 Scope of the Report
    • 1.1 Market Introduction
    • 1.2 Research Objectives
    • 1.3 Years Considered
    • 1.4 Market Research Methodology
    • 1.5 Economic Indicators
    • 1.6 Currency Considered
  • 2 Executive Summary
    • 2.1 World Market Overview
      • 2.1.1 Global Nucleic Acid-based Therapeutics Market Size 2013-2023
      • 2.1.2 Nucleic Acid-based Therapeutics Market Size CAGR by Region
    • 2.2 Nucleic Acid-based Therapeutics Segment by Type
      • 2.2.1 Anti-Sense And Anti-Gene
      • 2.2.2 Short Inhibitory Sequences
      • 2.2.3 Gene Transfer Therapy
      • 2.2.4 Nucleoside Analogs
      • 2.2.5 Ribozymes
      • 2.2.6 Aptamers
    • 2.3 Nucleic Acid-based Therapeutics Market Size by Type
      • 2.3.1 Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
      • 2.3.2 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2013-2018)
    • 2.4 Nucleic Acid-based Therapeutics Segment by Application
      • 2.4.1 Monogenetic Disorders
      • 2.4.2 Multi-Genetic Disorders
    • 2.5 Nucleic Acid-based Therapeutics Market Size by Application
      • 2.5.1 Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
      • 2.5.2 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Application (2013-2018)
  • 3 Global Nucleic Acid-based Therapeutics by Players
    • 3.1 Global Nucleic Acid-based Therapeutics Market Size Market Share by Players
      • 3.1.1 Global Nucleic Acid-based Therapeutics Market Size by Players (2016-2018)
      • 3.1.2 Global Nucleic Acid-based Therapeutics Market Size Market Share by Players (2016-2018)
    • 3.2 Global Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Nucleic Acid-based Therapeutics by Regions
    • 4.1 Nucleic Acid-based Therapeutics Market Size by Regions
    • 4.2 Americas Nucleic Acid-based Therapeutics Market Size Growth
    • 4.3 APAC Nucleic Acid-based Therapeutics Market Size Growth
    • 4.4 Europe Nucleic Acid-based Therapeutics Market Size Growth
    • 4.5 Middle East & Africa Nucleic Acid-based Therapeutics Market Size Growth
  • 5 Americas
    • 5.1 Americas Nucleic Acid-based Therapeutics Market Size by Countries
    • 5.2 Americas Nucleic Acid-based Therapeutics Market Size by Type
    • 5.3 Americas Nucleic Acid-based Therapeutics Market Size by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Key Economic Indicators of Few Americas Countries
  • 6 APAC
  • 6.1 APAC Nucleic Acid-based Therapeutics Market Size by Countries
    • 6.2 APAC Nucleic Acid-based Therapeutics Market Size by Type
    • 6.3 APAC Nucleic Acid-based Therapeutics Market Size by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 Key Economic Indicators of Few APAC Countries
  • 7 Europe
    • 7.1 Europe Nucleic Acid-based Therapeutics by Countries
    • 7.2 Europe Nucleic Acid-based Therapeutics Market Size by Type
    • 7.3 Europe Nucleic Acid-based Therapeutics Market Size by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Spain
    • 7.10 Key Economic Indicators of Few Europe Countries
  • 8 Middle East & Africa
    • 8.1 Middle East & Africa Nucleic Acid-based Therapeutics by Countries
    • 8.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type
    • 8.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
    • 9.1 Market Drivers and Impact
      • 9.1.1 Growing Demand from Key Regions
      • 9.1.2 Growing Demand from Key Applications and Potential Industries
    • 9.2 Market Challenges and Impact
    • 9.3 Market Trends
  • 10 Global Nucleic Acid-based Therapeutics Market Forecast
    • 10.1 Global Nucleic Acid-based Therapeutics Market Size Forecast (2018-2023)
    • 10.2 Global Nucleic Acid-based Therapeutics Forecast by Regions
      • 10.2.1 Global Nucleic Acid-based Therapeutics Forecast by Regions (2018-2023)
      • 10.2.2 Americas Market Forecast
      • 10.2.3 APAC Market Forecast
      • 10.2.4 Europe Market Forecast
      • 10.2.5 Middle East & Africa Market Forecast
    • 10.3 Americas Forecast by Countries
      • 10.3.1 United States Market Forecast
      • 10.3.2 Canada Market Forecast
      • 10.3.3 Mexico Market Forecast
      • 10.3.4 Brazil Market Forecast
    • 10.4 APAC Forecast by Countries
      • 10.4.1 China Market Forecast
      • 10.4.2 Japan Market Forecast
      • 10.4.3 Korea Market Forecast
      • 10.4.4 Southeast Asia Market Forecast
      • 10.4.5 India Market Forecast
      • 10.4.6 Australia Market Forecast
    • 10.5 Europe Forecast by Countries
      • 10.5.1 Germany Market Forecast
      • 10.5.2 France Market Forecast
      • 10.5.3 UK Market Forecast
      • 10.5.4 Italy Market Forecast
      • 10.5.5 Russia Market Forecast
      • 10.5.6 Spain Market Forecast
    • 10.6 Middle East & Africa Forecast by Countries
      • 10.6.1 Egypt Market Forecast
      • 10.6.2 South Africa Market Forecast
      • 10.6.3 Israel Market Forecast
      • 10.6.4 Turkey Market Forecast
      • 10.6.5 GCC Countries Market Forecast
    • 10.7 Global Nucleic Acid-based Therapeutics Forecast by Type
    • 10.8 Global Nucleic Acid-based Therapeutics Forecast by Application
  • 11 Key Players Analysis
    • 11.1 Wave Life Sciences
      • 11.1.1 Company Details
      • 11.1.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.1.4 Main Business Overview
      • 11.1.5 Wave Life Sciences News
    • 11.2 Imugene
      • 11.2.1 Company Details
      • 11.2.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.2.3 Imugene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.2.4 Main Business Overview
      • 11.2.5 Imugene News
    • 11.3 Caperna
      • 11.3.1 Company Details
      • 11.3.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.3.3 Caperna Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.3.4 Main Business Overview
      • 11.3.5 Caperna News
    • 11.4 Phylogica
      • 11.4.1 Company Details
      • 11.4.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.4.3 Phylogica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.4.4 Main Business Overview
      • 11.4.5 Phylogica News
    • 11.5 Protagonist Therapeutics
      • 11.5.1 Company Details
      • 11.5.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.5.4 Main Business Overview
      • 11.5.5 Protagonist Therapeutics News
    • 11.6 Benitec Biopharma
      • 11.6.1 Company Details
      • 11.6.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.6.4 Main Business Overview
      • 11.6.5 Benitec Biopharma News
    • 11.7 EGEN
      • 11.7.1 Company Details
      • 11.7.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.7.3 EGEN Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.7.4 Main Business Overview
      • 11.7.5 EGEN News
    • 11.8 BioMedica
      • 11.8.1 Company Details
      • 11.8.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.8.3 BioMedica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.8.4 Main Business Overview
      • 11.8.5 BioMedica News
    • 11.9 Transgene
      • 11.9.1 Company Details
      • 11.9.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.9.3 Transgene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.9.4 Main Business Overview
      • 11.9.5 Transgene News
    • 11.10 Copernicus Therapeutics
      • 11.10.1 Company Details
      • 11.10.2 Nucleic Acid-based Therapeutics Product Offered
      • 11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
      • 11.10.4 Main Business Overview
      • 11.10.5 Copernicus Therapeutics News
  • 12 Research Findings and Conclusion

Request a FREE Sample


Our Happy Customers

Request a FREE Sample